The Characteristics of Patients whose both Fasting and Postprandial Glucose were Controlled by Once Daily Basal Insulin MonotherapyMi-Kyung KIM1,2*
- *Corresponding Author:
- Mi-kyung KIM
Department of Internal Medicine
Haeundae Paik Hospital, College of Medicine
Inje University, 875, Haeundae-ro
Haeundae-gu, Busan, 612-862, Republic of Korea
Tel: 82 51 797 0636
Fax:82 51 797 2070
E-mail: [email protected]
Received date: January 21, 2016; Accepted date: February 02, 2016; Published date: February 06, 2016
Citation: Mi-Kyung KIM (2016) The Characteristics of Patients whose both Fasting and Postprandial Glucose were Controlled by Once Daily Basal Insulin Monotherapy. J Diabetes Metab 7:645. doi: 10.4172/2155-6156.1000645
Copyright: © 2016 Mi-Kyung KIM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Background: Several meta-analyses compared insulin monotherapy and combined therapy of insulin and oral hypoglycemic agents (OHA). However, these were not consistent and not focused to individualization. Therefore, we try to elucidate the characteristics of patients whose both fasting and postprandial glucose were controlled by once daily basal insulin monotherapy. Methods: The data of this study are part of our previous study which investigated characteristics of responders on different medications for controlling postprandial glucose levels after optimizing fasting glucose levels by insulin glargine. Background OHA cessation for 2 weeks of initial washout period and then insulin glargine was initiated. Oral glucose tolerance tests after initial wash out period and 7 point self-monitoring blood glucose test for 3 days at each step was completed by each subject. Results: The patients in Controlled group were younger, had a lower baseline A1c, and lower OGTT 2hr PPG levels than patients in the Non-Controlled group. Controlled group showed higher homeostasis model analysis % β (HOMA %B), corrected insulin response (CIR) and insulin-to-glucose ratio (IGR) than Non-Controlled group. Homeostasis model analysis insulin resistance (HOMA IR), 1/fasting insulin (by FI) and insulin sensitivity index (ISI) were similar between the two groups. Conclusions: In our study, some patients can be well controlled both fasting and postprandial glucose level with once daily insulin glargine monotherapy. Patients able to do so were younger, had lower baseline HbA1c, lower oral glucose tolerance test (OGTT) 2h PPG and higher makers of insulin secretion.